ETTX
Vanguard Group’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-502,622
| Closed | -$1.11M | – | 4656 |
|
|
2022
Q2 | $1.11M | Buy |
502,622
+18,899
| +4% | +$41.6K | ﹤0.01% | 4055 |
|
|
2022
Q1 | $905K | Buy |
483,723
+33,768
| +8% | +$63.2K | ﹤0.01% | 4239 |
|
|
2021
Q4 | $986K | Buy |
449,955
+23,720
| +6% | +$52K | ﹤0.01% | 4269 |
|
|
2021
Q3 | $1.42M | Buy |
426,235
+6,238
| +1% | +$20.8K | ﹤0.01% | 4160 |
|
|
2021
Q2 | $1.12M | Buy |
419,997
+214,831
| +105% | +$573K | ﹤0.01% | 4126 |
|
|
2021
Q1 | $439K | Buy |
205,166
+72,007
| +54% | +$154K | ﹤0.01% | 4153 |
|
|
2020
Q4 | $329K | Buy |
133,159
+34,400
| +35% | +$85K | ﹤0.01% | 4028 |
|
|
2020
Q3 | $201K | Buy |
98,759
+44,233
| +81% | +$90K | ﹤0.01% | 3954 |
|
|
2020
Q2 | $161K | Hold |
54,526
| – | – | ﹤0.01% | 3944 |
|
|
2020
Q1 | $144K | Hold |
54,526
| – | – | ﹤0.01% | 3904 |
|
|
2019
Q4 | $271K | Hold |
54,526
| – | – | ﹤0.01% | 3901 |
|
|
2019
Q3 | $318K | Buy |
54,526
+5,429
| +11% | +$31.7K | ﹤0.01% | 3890 |
|
|
2019
Q2 | $317K | Hold |
49,097
| – | – | ﹤0.01% | 3896 |
|
|
2019
Q1 | $332K | Hold |
49,097
| – | – | ﹤0.01% | 3835 |
|
|
2018
Q4 | $200K | Buy |
+49,097
| New | +$200K | ﹤0.01% | 3906 |
|